Business
further instalment of grant
further instalment of grant.
About this update from Immupharma Plc
[{"type":"text","content":"\n RNS Number : 5869K Immupharma PLC 22 December 2008 \n \nFor Immediate Release 22 December 2008\n \n\nImmuPharma plc\nImmuPharma receives further instalment of grant for developing cancer drug \nImmuPharma PLC (LSE:IMM), ('ImmuPharma or the 'Company') the specialist drug discovery and development company, is pleased to announce that it has been awarded a further instalment of a grant (see press release dated 12 November 2008) from French government organisations bringing the total received to €1.15m. The grants are to be used for the development of ImmuPharma's cancer drug candidate IPP-204106.\nDr. Robert Zimmer, President & Chief Scientific Officer said: 'We are both delighted and honoured to have been chosen for the grant by this prestigious French government organisation. Together with the company's internal resources, this grant will fund the development of our exciting cancer compound to the completion of Phase I trials, which we expect to start during 2009.' \n\n \nFor further information please contact:\nImmuPharma PLC Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080\nDr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 7650\nRichard ...